Intracellular osteopontin stabilizes TRAF3 to positively regulate innate antiviral response

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhao, Kai ^a   Zhang, Meng ^b   Zhang, Lei ^a   Wang, Peng ^a   Song, Guanhua ^a   Liu, Bingyu ^a   Wu, Haifeng ^a   Yin, Zhinan ^c   Gao, Chengjiang ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; IRF3 PROTEIN, HUMAN; OSTEOPONTIN; PROTEIN BINDING; SPP1 PROTEIN, HUMAN; TRAF3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

A-549 CELL LINE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; FEMALE; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; METABOLISM; PERITONEUM MACROPHAGE; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN STABILITY; SENDAI VIRUS; UBIQUITINATION; VESICULOVIRUS; VIROLOGY;

A549 CELLS; ANIMALS; FEMALE; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MACROPHAGES, PERITONEAL; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOPONTIN; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; SENDAI VIRUS; TNF RECEPTOR-ASSOCIATED FACTOR 3; UBIQUITINATION; VESICULOVIRUS;

EID: 84962349426     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23771     Document Type: Article

References (43)

1. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
2. Samuel, C. E. Antiviral actions of interferons. Clin. Microbiol. 14, 778-809 (2001).
3. Creagh, E. M. & O'Neill, L. A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27, 352-357 (2006).
4. Kawai, T. & Akira, S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY. Acad. Sci. 1143, 1-20 (2008).
5. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
6. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145 (2001).
7. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
8. Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19-28 (2005).
9. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
10. Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF3. Cell 122, 669-682 (2005).
11. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988 (2005).
12. Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172 (2005).
13. Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727-740 (2005).
14. Saha, S. K. et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25, 3257-3263 (2006).
15. Nakhaei, P., Genin, P., Civas, A. & Hiscott, J. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin. Immunol. 21, 215-222 (2009).
16. Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
17. Hu, H. M., O'Rourke, K., Boguski, M. S. & Dixit, V. M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072 (1994).
18. Cheng, G. et al. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498 (1995).
19. Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208-211 (2006).
20. Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006).
21. Paz, S. et al. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21, 895-910 (2011).
22. Nakhaei, P. et al. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. Plos Pathog. 5, e1000650 (2009).
23. Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628-1632 (2007).
24. Shinohara, M. L., Kim, H. J., Kim, J. H., Garcia, V. A. & Cantor, H. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc. Natl. Acad. Sci. USA 105, 7235-7239 (2008).
25. Wang, B. X. & Fish E. N. The yin and yang of viruses and interferons. Trends Immunol. 33, 190-197 (2012).
26. Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087-1095 (1998).
27. Lin, R., Mustafa, A., Nguyen, H., Gewert, D. & Hiscott, J. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression. J. Bio. Chem. 269, 17542-17549 (1994).
28. Wathelet, M. G. et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. cell 1, 507-518 (1998).
29. Tseng, P. H. et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11, 70-75 (2010).
30. Zhong, B. et al. Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3. Sci. Signal. 6, ra35 (2013).
31. Lin, D. et al. Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6. Proc. Natl. Acad. Sci. USA 112, 11324-11329 (2015).
32. Agnihotri, R. et al. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J. Bio. Chem. 276, 28261-28267 (2001).
33. Brown, A. et al. Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. J. Neurovirol. 17, 382-392 (2011).
34. Sato, K. et al. Osteopontin is critical to determine symptom severity of influenza through the regulation of NK cell population. Biochem. Biophs. Res. Commun. 417, 274-279 (2012).
35. Abel, B., Freigang, S., Bachmann, M. F., Boschert, U. & Kopf, M. Osteopontin is not required for the development of Th1 responses and viral immunity. J. Immunol. 175, 6006-6013 (2005).
36. Shinohara, M. L. et al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7, 498-506 (2006).
37. Inoue, M. et al. Cutting edge: critical role of intracellular osteopontin in antifungal innate immune responses. J. Immunol. 186, 19-23 (2011).
38. Inoue, M. et al. T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation. Proc. Natl. Acad. Sci. USA 111, 5295-5300 (2014).
39. Leavenworth, J. W., Verbinnen, B., Yin, J., Huang, H. & Cantor, H. A p85alpha-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells. Nat. Immunol. 16, 96-106 (2015).
40. Wang, P., Zhao, W., Zhao, K., Zhang, L. & Gao, C. TRIM26 negatively regulates interferon-beta production and antiviral response through polyubiquitination and degradation of nuclear IRF3. Plos Pathog. 11, e1004726 (2015).
41. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008).
42. Zhang, M. et al. TRAF-interacting protein (TRIP) negatively regulates IFN-beta production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J. Exp. Med. 209, 1703-1711 (2012).
43. Mori, M. et al. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Bio. Chem. 279, 9698-9702 (2004).